Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. cut its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 96.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 44,121 shares of the company's stock after selling 1,123,433 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Bath & Body Works were worth $1,711,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in BBWI. Fifth Third Wealth Advisors LLC lifted its holdings in Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock worth $271,000 after buying an additional 324 shares during the last quarter. TD Private Client Wealth LLC raised its position in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after acquiring an additional 331 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Bath & Body Works by 34.4% in the third quarter. GAMMA Investing LLC now owns 2,481 shares of the company's stock valued at $79,000 after purchasing an additional 635 shares in the last quarter. Everett Harris & Co. CA boosted its holdings in Bath & Body Works by 1.5% in the third quarter. Everett Harris & Co. CA now owns 49,140 shares of the company's stock valued at $1,569,000 after purchasing an additional 725 shares in the last quarter. Finally, Sequoia Financial Advisors LLC increased its stake in Bath & Body Works by 14.9% in the third quarter. Sequoia Financial Advisors LLC now owns 6,514 shares of the company's stock valued at $208,000 after purchasing an additional 847 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on BBWI. Barclays upped their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an "underweight" rating in a report on Tuesday, November 26th. JPMorgan Chase & Co. raised their price objective on Bath & Body Works from $39.00 to $41.00 and gave the stock a "neutral" rating in a report on Friday. Piper Sandler lifted their target price on Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upped their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $43.19.

Bath & Body Works Price Performance

NYSE BBWI traded down $0.31 during mid-day trading on Friday, hitting $36.98. The company's stock had a trading volume of 2,087,776 shares, compared to its average volume of 3,125,232. The firm has a market capitalization of $8.01 billion, a P/E ratio of 9.02, a price-to-earnings-growth ratio of 1.01 and a beta of 1.82. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99. The stock's fifty day simple moving average is $36.86 and its two-hundred day simple moving average is $33.66.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the firm posted $0.48 EPS. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works's payout ratio is 19.51%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.